Volume 70, Issue 6, Pages (September 2006)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 72, Issue 7, Pages (October 2007)
Volume 68, Issue 4, Pages (October 2005)
Volume 77, Issue 9, Pages (May 2010)
Tiffany Shao, Jordan Weinstein, Serge Jothy, Marc Goldstein 
Osteopontin expression in acute renal allograft rejection
Volume 72, Issue 10, Pages (November 2007)
Histomorphology in a case of mixed (cellular and humoral) acute kidney allograft rejection (patient 10). Histomorphology in a case of mixed (cellular and.
Volume 79, Issue 6, Pages (March 2011)
Volume 67, Issue 4, Pages (April 2005)
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 86, Issue 3, Pages (September 2014)
Volume 70, Issue 7, Pages (October 2006)
Volume 82, Issue 3, Pages (August 2012)
Volume 58, Issue 4, Pages (October 2000)
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
C.-W. Tsai, V.-C. Wu, W.-C. Lin, J.-W. Huang, M.-S. Wu
Volume 73, Issue 5, Pages (March 2008)
Volume 71, Issue 10, Pages (May 2007)
Volume 84, Issue 4, Pages (October 2013)
Volume 60, Issue 1, Pages (July 2001)
Volume 70, Issue 12, Pages (December 2006)
Peritubular capillaritis in the renal allograft takes center stage
Apoptosis in the kidneys of patients with type II diabetic nephropathy
Renoprotective immunosuppression by pioglitazone with low-dose cyclosporine in rat heart transplantation  Yosuke Tanaka, MD, Tomomi Hasegawa, MD, PhD,
Volume 68, Issue 4, Pages (October 2005)
Infection and chronic allograft dysfunction
Volume 70, Issue 8, Pages (October 2006)
Volume 64, Issue 5, Pages (November 2003)
Volume 70, Issue 11, Pages (December 2006)
Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,
Volume 66, Issue 3, Pages (September 2004)
Volume 69, Issue 10, Pages (May 2006)
Proteasome inhibitor-based therapy for antibody-mediated rejection
Volume 78, Issue 10, Pages (November 2010)
Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin 
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 73, Issue 5, Pages (March 2008)
An unusual cause of acute renal failure
Volume 72, Issue 2, Pages (July 2007)
Volume 62, Issue 2, Pages (August 2002)
Volume 72, Issue 7, Pages (October 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 72, Issue 8, Pages (October 2007)
What can be learned using microarrays?
Volume 69, Issue 11, Pages (June 2006)
Volume 71, Issue 4, Pages (February 2007)
The treatment of acute interstitial nephritis: More data at last
Volume 76, Issue 12, Pages (December 2009)
Organ transplantation goes to the movies
Volume 69, Issue 1, Pages (January 2006)
Inflammatory cells in ischemic acute renal failure
D. Fuster, A. Monegal, J.-V. Torregrosa  Kidney International 
Volume 69, Issue 10, Pages (May 2006)
BK virus nephritis after renal transplantation
Volume 70, Issue 3, Pages (August 2006)
A nest in renal fibrosis?
Volume 71, Issue 9, Pages (May 2007)
Volume 72, Issue 6, Pages (September 2007)
The more or less ‘pristine’ renal allograft biopsy
Volume 73, Issue 5, Pages (March 2008)
Volume 70, Issue 5, Pages (September 2006)
T cells and T-cell receptors in acute renal failure
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status  Kathryn J. Tinckam, Ognjenka Djurdjev, Alex.
Volume 72, Issue 12, (December 2007)
Development and differentiation of endothelium
Volume 70, Issue 6, Pages (September 2006)
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Volume 70, Issue 6, Pages 1127-1134 (September 2006) Renal expression of CD44 correlates with acute renal allograft rejection  K.M.A. Rouschop, J.J.T.H. Roelofs, M. Sylva, A.T. Rowshani, I.J.M. ten Berge, J.J. Weening, S. Florquin  Kidney International  Volume 70, Issue 6, Pages 1127-1134 (September 2006) DOI: 10.1038/sj.ki.5001711 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 CD44-expression is increased during acute renal allograft rejection. Renal biopsies of patients during allograft rejection and non-rejecting biopsies were immunohistochemically stained for CD44. In non-rejecting biopsies, interstitial cells and capillary endothelial cells express CD44. During renal rejection, CD44 is also detected on infiltrating cells, vascular endothelium (black arrow), and TECs (white arrow). Kidney International 2006 70, 1127-1134DOI: (10.1038/sj.ki.5001711) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Increased tubular CD44 during acute renal allograft rejection. Semiquantitative scoring of renal biopsies revealed statistically significantly increased tubular CD44 (a) expression and infiltrate (b) in biopsies of renal allografts during acute rejection. No differences were observed in the expression of (c) glomerular- or (d) vascular endothelial CD44. *P<0.05; **P<0.01; ***P<0.001 as determined by Kruskall–Wallis test. Tubular CD44 expression correlated to CD44 expressed by the (e) infiltrate, (r=0.70, P<0.0001) as determined by a Spearman rho test. Kidney International 2006 70, 1127-1134DOI: (10.1038/sj.ki.5001711) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Expression of the CD44 ligands osteopontin and HA. (a) HA stained area was determined by digital image analysis. All transplant biopsies stained positive for HA. In acute rejection type I, renal HA is upregulated. Representative micrographs of HA staining in biopsies of non-rejecting patients or patients with acute rejection type I are shown next to the graph. (b) Immunohistochemical staining of renal biopsies revealed osteopontin expression in 17 of 23 patients with acute rejection. No staining was observed in transplant patients without acute allograft rejection. Representative micrographs of osteopontin staining in biopsies of non-rejecting patients or patients with acute rejection type I are shown next to the graph. *P<0.05 as determined by Kruskall–Wallis test. Kidney International 2006 70, 1127-1134DOI: (10.1038/sj.ki.5001711) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 Increased sCD44 levels during acute renal allograft rejection. (a) sCD44 levels in the plasma were determined by enzyme-linked immunosorbent assay. Non-rejectors and healthy volunteers had comparable sCD44 levels. sCD44 was increased in patients suffering rejection. No statistically significant differences were observed between different types of rejection. (b) Soluble osteopontin levels were increased in transplant patients without acute rejection compared to healthy volunteers. No differences were observed in the transplanted patients. *P<0.05; **P<0.01 as determined by Kruskall–Wallis test. Kidney International 2006 70, 1127-1134DOI: (10.1038/sj.ki.5001711) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Correlation between sCD44 and tubular CD44. sCD44 levels in plasma correlate to (a) creatinine levels in acute renal rejection. sCD44 correlates to (b) tubular expression of CD44 and (c) CD44 expressed by infiltrating cells in biopsies of acute renal allograft rejection. sCD44 is inversely correlated to CD44 expressed by (d) glomerular endothelium but not to (e) vascular endothelium. Correlation was determined using a Spearman rho test. Kidney International 2006 70, 1127-1134DOI: (10.1038/sj.ki.5001711) Copyright © 2006 International Society of Nephrology Terms and Conditions